New Patents Issued to Diffusion Pharmaceuticals
Lead drug trans sodium crocetinate receives new patent protection through 2027
20-Aug-2012 -
Diffusion Pharmaceuticals LLC announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled “Bipolar Trans Carotenoids Salts and Their Uses” and “Trans Carotenoids, Their Synthesis and Uses,” respectively. These patents include compound, ...
patents